focus -WSS

focus

author：comprehensive 2025-09-29 07:16:17 - browse：851

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

In a clinical trial, Casgevy was shown to eliminate recurrent episodes of debilitating pain caused by sickle cell, which afflicts approximately 100,000 people in the U.S., a vast majority of whom are Black. The therapy, whose scientific name is exa-cel, is described as a potential cure because the genetic fix enabled by CRISPR is designed to last a lifetime, although confirmation will require years of follow-up.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

hotspot

WSS

Man killed during FBI raid in connection with threats against Biden, other officials

For Cytokinetics, FDA rejection of heart drug would help, not hinder

The best solution to the drug shortages problem

Former medical device CEO who sold dummy, plastic parts convicted of fraud

First medicine developed to treat MASH expected to be approved soon

Friends ask where James Watson's attitudes about race came from

hotspot

focus

focus

In Memoriam: Notable people who died in 2023

For Cytokinetics, FDA rejection of heart drug would help, not hinder

BioMarin wins approval for gene therapy to treat hemophilia A

Emergent cuts jobs, executive role in business shake

Cancer drug shortages should be causing more outrage

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Continuity nursing helped my family in our darkest PICU moments

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Amylyx ALS drug failure raises questions and concerns

knowledge

American woman, child freed after being kidnapped in Haiti last month

South Korea throws huge K

Headspace, Meta partner to launch VR meditation app for Quest

NEJM study link tiny plastics in blood vessels to heart problems

RSV shot was 90% effective at preventing hospitalizations in kids

RSV shot was 90% effective at preventing hospitalizations in kids

entertainment

hotspot

focus

entertainment